(LTC) LTC Properties - Ratings and Ratios
Senior Housing, Skilled Nursing
EPS (Earnings per Share)
Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 18.0% |
| Value at Risk 5%th | 30.4% |
| Relative Tail Risk | 2.39% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.12 |
| Alpha | -5.93 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.405 |
| Beta | 0.195 |
| Beta Downside | 0.088 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.17% |
| Mean DD | 8.64% |
| Median DD | 8.33% |
Description: LTC LTC Properties November 12, 2025
LTC Properties Inc. (NYSE:LTC) is a U.S.-based REIT that acquires, develops, and manages senior-housing and skilled-nursing facilities. Its investment approach mixes direct ownership through the Real Estate Investment Development Agreement (RIDEA) structure, triple-net leases, joint-venture partnerships, and structured-finance solutions, giving it flexibility to capture upside while limiting operational risk. The portfolio comprises roughly 200 properties in about 25 states, operated by more than 25 partner operators, with capital equally split between senior-housing and skilled-nursing assets.
As of the most recent FY2023 filing, LTC reported a funds-from-operations (FFO) of $0.49 per share, a dividend yield near 6.5%, and an occupancy rate of 92% across its senior-housing inventory-both metrics that exceed the sector average of roughly 88% occupancy and 5.5% yield. The REIT’s leverage stands at a debt-to-EBITDA ratio of 5.2×, reflecting a moderate risk profile relative to peers that typically trade around 5.5×.
The senior-housing and skilled-nursing market is driven primarily by U.S. demographic trends: the 65-plus population is projected to grow from 56 million in 2023 to over 78 million by 2035, sustaining demand for LTC-type facilities. At the same time, Medicare and Medicaid reimbursement policies, as well as the prevailing interest-rate environment, materially influence cash-flow stability and valuation multiples for health-care REITs.
For a deeper, data-rich analysis of LTC’s valuation dynamics, you might explore the company’s profile on ValueRay, where interactive metrics can help you test sensitivity scenarios and compare peers.
LTC Stock Overview
| Market Cap in USD | 1,706m |
| Sub-Industry | Health Care REITs |
| IPO / Inception | 1992-08-17 |
| Return 12m vs S&P 500 | -10.6% |
| Analyst Rating | 3.25 of 5 |
LTC Dividends
| Metric | Value |
|---|---|
| Dividend Yield | 6.87% |
| Yield on Cost 5y | 9.07% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 91.1% |
| Payout Ratio | 41.4% |
LTC Growth Ratios
| Metric | Value |
|---|---|
| CAGR 3y | 4.92% |
| CAGR/Max DD Calmar Ratio | 0.26 |
| CAGR/Mean DD Pain Ratio | 0.57 |
| Current Volume | 518.5k |
| Average Volume | 408.6k |
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income (33.9m TTM) > 0 and > 6% of Revenue (6% = 13.7m TTM) |
| FCFTA 0.06 (>2.0%) and ΔFCFTA 0.56pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 204.3% (prev 287.8%; Δ -83.47pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.06 (>3.0%) and CFO 131.3m > Net Income 33.9m (YES >=105%, WARN >=100%) |
| Net Debt (929.2m) to EBITDA (113.0m) ratio: 8.22 <= 3.0 (WARN <= 3.5) |
| Current Ratio 21.93 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (46.1m) change vs 12m ago 3.89% (target <= -2.0% for YES) |
| Gross Margin 80.22% (prev 93.57%; Δ -13.36pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 11.66% (prev 11.08%; Δ 0.58pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.50 (EBITDA TTM 113.0m / Interest Expense TTM 30.8m) >= 6 (WARN >= 3) |
Altman Z'' 1.06
| (A) 0.23 = (Total Current Assets 488.9m - Total Current Liabilities 22.3m) / Total Assets 2.04b |
| (B) -0.09 = Retained Earnings (Balance) -190.6m / Total Assets 2.04b |
| (C) 0.04 = EBIT TTM 76.9m / Avg Total Assets 1.96b |
| (D) -0.38 = Book Value of Equity -379.4m / Total Liabilities 999.2m |
| Total Rating: 1.06 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 63.29
| 1. Piotroski 2.50pt |
| 2. FCF Yield 4.94% |
| 3. FCF Margin 56.98% |
| 4. Debt/Equity 0.99 |
| 5. Debt/Ebitda 8.22 |
| 6. ROIC - WACC (= -0.07)% |
| 7. RoE 3.53% |
| 8. Rev. Trend 76.07% |
| 9. EPS Trend 7.43% |
What is the price of LTC shares?
Over the past week, the price has changed by +0.25%, over one month by +2.73%, over three months by +1.59% and over the past year by -0.14%.
Is LTC a buy, sell or hold?
- Strong Buy: 1
- Buy: 1
- Hold: 5
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the LTC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 38 | 5.6% |
| Analysts Target Price | 38 | 5.6% |
| ValueRay Target Price | 39.3 | 9.1% |
LTC Fundamental Data Overview November 21, 2025
P/E Trailing = 49.75
P/E Forward = 12.4533
P/S = 7.5138
P/B = 1.8124
P/EG = 5.41
Beta = 0.621
Revenue TTM = 228.4m USD
EBIT TTM = 76.9m USD
EBITDA TTM = 113.0m USD
Long Term Debt = 396.1m USD (from longTermDebt, last quarter)
Short Term Debt = 944.5m USD (from shortTermDebt, last quarter)
Debt = 947.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 929.2m USD (from netDebt column, last quarter)
Enterprise Value = 2.63b USD (1.71b + Debt 947.2m - CCE 17.9m)
Interest Coverage Ratio = 2.50 (Ebit TTM 76.9m / Interest Expense TTM 30.8m)
FCF Yield = 4.94% (FCF TTM 130.1m / Enterprise Value 2.63b)
FCF Margin = 56.98% (FCF TTM 130.1m / Revenue TTM 228.4m)
Net Margin = 14.83% (Net Income TTM 33.9m / Revenue TTM 228.4m)
Gross Margin = 80.22% ((Revenue TTM 228.4m - Cost of Revenue TTM 45.2m) / Revenue TTM)
Gross Margin QoQ = 70.28% (prev 68.11%)
Tobins Q-Ratio = 1.29 (Enterprise Value 2.63b / Total Assets 2.04b)
Interest Expense / Debt = 0.69% (Interest Expense 6.50m / Debt 947.2m)
Taxrate = -0.23% (negative due to tax credits) (42.0k / -18.5m)
NOPAT = 77.1m (EBIT 76.9m * (1 - -0.23%)) [negative tax rate / tax credits]
Current Ratio = 21.93 (Total Current Assets 488.9m / Total Current Liabilities 22.3m)
Debt / Equity = 0.99 (Debt 947.2m / totalStockholderEquity, last quarter 957.9m)
Debt / EBITDA = 8.22 (Net Debt 929.2m / EBITDA 113.0m)
Debt / FCF = 7.14 (Net Debt 929.2m / FCF TTM 130.1m)
Total Stockholder Equity = 959.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.66% (Net Income 33.9m / Total Assets 2.04b)
RoE = 3.53% (Net Income TTM 33.9m / Total Stockholder Equity 959.5m)
RoCE = 5.67% (EBIT 76.9m / Capital Employed (Equity 959.5m + L.T.Debt 396.1m))
RoIC = 4.50% (NOPAT 77.1m / Invested Capital 1.71b)
WACC = 4.57% (E(1.71b)/V(2.65b) * Re(6.73%) + D(947.2m)/V(2.65b) * Rd(0.69%) * (1-Tc(-0.00)))
Discount Rate = 6.73% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 4.74%
[DCF Debug] Terminal Value 80.84% ; FCFE base≈121.5m ; Y1≈143.7m ; Y5≈222.2m
Fair Price DCF = 79.94 (DCF Value 3.81b / Shares Outstanding 47.6m; 5y FCF grow 19.41% → 3.0% )
EPS Correlation: 7.43 | EPS CAGR: 3.05% | SUE: 1.96 | # QB: 1
Revenue Correlation: 76.07 | Revenue CAGR: 13.30% | SUE: 0.08 | # QB: 0
Additional Sources for LTC Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle